Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy DOI Creative Commons
Hong Liang,

Jiangmin Li,

Yali Luo

et al.

Biomolecules, Journal Year: 2022, Volume and Issue: 12(1), P. 81 - 81

Published: Jan. 5, 2022

Photodynamic therapy (PDT) is a treatment modality that uses light to target tumors and minimize damage normal tissues. It offers advantages including high spatiotemporal selectivity, low side effects, maximal preservation of tissue functions. However, the PDT efficiency severely impeded by hypoxic feature tumors. Moreover, hypoxia may promote tumor metastasis resistance multiple therapies. Therefore, addressing improve efficacy has been focus antitumor treatment, research on this theme continuously emerging. In review, we summarize state-of-the-art advances in strategies for overcoming PDTs, categorizing them into oxygen-independent phototherapy, oxygen-economizing PDT, oxygen-supplementing PDT. highlight possessing intriguing such as exceedingly novelty, analyze strengths shortcomings different methods, envision opportunities challenges future research.

Language: Английский

Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis DOI Creative Commons
Jianlin Zuo,

Jinshuo Tang,

Meng Lü

et al.

Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12

Published: Nov. 24, 2021

Rheumatoid arthritis (RA) is a classic autoimmune disease characterized by uncontrolled synovial proliferation, pannus formation, cartilage injury, and bone destruction. The specific pathogenesis of RA, chronic inflammatory disease, remains unclear. However, both key glycolysis rate-limiting enzymes, hexokinase-II (HK-II), phosphofructokinase-1 (PFK-1), pyruvate kinase M2 (PKM2), as well indirect 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), are thought to participate in the RA. In here, we review latest literature on introduce pathophysiological characteristics HK-II, PFK-1/PFKFB3, PKM2 their expression this systematically assess association between glycolytic enzymes RA from molecular level. Moreover, highlight potential targets for clinical treatment There great develop new anti-rheumatic therapies through safe inhibition or overexpression enzymes.

Language: Английский

Citations

95

Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes DOI
Michele Coluccia,

Valeria Parisse,

Paolo Guglielmi

et al.

European Journal of Medicinal Chemistry, Journal Year: 2022, Volume and Issue: 244, P. 114801 - 114801

Published: Oct. 4, 2022

Language: Английский

Citations

63

Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism DOI Creative Commons
Abhilasha Sharma, Sonam Sinha, Neeta Shrivastava

et al.

Frontiers in Genetics, Journal Year: 2022, Volume and Issue: 13

Published: March 31, 2022

Metabolic alterations are one of the hallmarks cancer, which has recently gained great attention. Increased glucose absorption and lactate secretion in cancer cells characterized by Warburg effect, is caused metabolic changes tumor tissue. Cancer switch from oxidative phosphorylation (OXPHOS) to aerobic glycolysis due degradation mechanisms, a process known as “metabolic reprogramming”. As result, proteins involved mediating altered pathways identified pose novel therapeutic targets. Hypoxic microenvironment (HTM) anticipated trigger promote alterations, oncogene activation, epithelial-mesenchymal transition, drug resistance, all aggressive behaviour. Angiogenesis, erythropoiesis, regulation, transport, acidosis regulators have been orchestrated through activation stability transcription factor termed hypoxia-inducible factor-1 (HIF-1), hence altering crucial effect activities. Therefore, targeting HIF-1 therapy seems like an extremely rational approach it directly shift In this mini-review, we present brief overview function hypoxic with particular focus on strategies currently available.

Language: Английский

Citations

60

Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems DOI Creative Commons
Alistair V.W. Nunn,

Geoffrey W. Guy,

Wolfgang Brysch

et al.

Biomedicines, Journal Year: 2022, Volume and Issue: 10(12), P. 3113 - 3113

Published: Dec. 2, 2022

Many people infected with the SARS-CoV-2 suffer long-term symptoms, such as "brain fog", fatigue and clotting problems. Explanations for "long COVID" include immune imbalance, incomplete viral clearance potentially, mitochondrial dysfunction. As conditions sub-optimal function are associated initial severity of disease, their prior health could be key in resistance to long COVID recovery. The SARs virus redirects host metabolism towards replication; response, can metabolically react control virus. Resolution is normally achieved after stress activates a hormetic negative feedback mechanism. It therefore possible that, some individuals function, "tip" into chronic inflammatory cycle. This might explain main including platelet Long thus described virally induced self-perpetuating imbalanced non-resolving state characterised by dysfunction, where reactive oxygen species continually drive inflammation shift glycolysis. would suggest that sufferer's needs "tipped" back using stimulus, physical activity, calorie restriction, or chemical compounds mimic these enhancing perhaps combination inhibitors quell response.

Language: Английский

Citations

54

Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy DOI Creative Commons
Hong Liang,

Jiangmin Li,

Yali Luo

et al.

Biomolecules, Journal Year: 2022, Volume and Issue: 12(1), P. 81 - 81

Published: Jan. 5, 2022

Photodynamic therapy (PDT) is a treatment modality that uses light to target tumors and minimize damage normal tissues. It offers advantages including high spatiotemporal selectivity, low side effects, maximal preservation of tissue functions. However, the PDT efficiency severely impeded by hypoxic feature tumors. Moreover, hypoxia may promote tumor metastasis resistance multiple therapies. Therefore, addressing improve efficacy has been focus antitumor treatment, research on this theme continuously emerging. In review, we summarize state-of-the-art advances in strategies for overcoming PDTs, categorizing them into oxygen-independent phototherapy, oxygen-economizing PDT, oxygen-supplementing PDT. highlight possessing intriguing such as exceedingly novelty, analyze strengths shortcomings different methods, envision opportunities challenges future research.

Language: Английский

Citations

49